{"id":"W4407700629","doi":"10.1200/jco.2025.43.5_suppl.159","title":"Secondary outcomes by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR) treated with enzalutamide (enza) plus leuprolide (combo): EMBARK post hoc analysis.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Oncology; Post-hoc analysis; Internal medicine; Post hoc; Cancer; Gynecology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003356775,0.0009183866,0.00197952,0.0004080674,0.0002349756,0.0006625357,0.0005416563,0.000688998,0.003673767],"category_scores_gemma":[0.002629442,0.0002439077,0.003898365,0.0003961726,0.0003976226,0.0008009925,0.000529036,0.001855155,0.000313991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005104652,"about_ca_system_score_gemma":0.0009391583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004476078,"about_ca_topic_score_gemma":0.001265899,"domain_scores_codex":[0.9987821,0.0006538467,0.0000926314,0.0001873556,0.000124162,0.0001598765],"domain_scores_gemma":[0.9973501,0.001238468,0.0006515237,0.000180101,0.0001149286,0.0004647718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9484419,0.003630022,0.0227161,0.000530475,0.004684219,0.00008577221,0.00004644863,0.001511576,0.002825126,0.00008182943,0.001018876,0.01442765],"study_design_scores_gemma":[0.1550923,0.5974628,0.2214905,0.0001194649,0.01072994,0.0002826902,0.0001624784,0.005458765,0.004984024,0.0006207147,0.003508902,0.00008749538],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951566,0.001087508,0.000400443,0.0001034077,0.00006590334,0.0006360415,0.001525517,0.00002573873,0.0009987984],"genre_scores_gemma":[0.9935555,0.0004299744,0.000614581,0.0001998164,0.0001469304,0.001240079,0.002534605,0.00001262188,0.001265749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003673767,"threshold_uncertainty_score":0.01775253,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03541493979559037,"score_gpt":0.4124272667645508,"score_spread":0.3770123269689604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}